Maxwell Technologies, Inc. (NASDAQ:MXWL) has lost 1.58% or $.29 a share to settle at $18.03 with a light volume of 31,144 shares compared to its average three-month volume of 144,830. For the past 52 weeks the stock has been trading between $10.16 and $19.65 a share with a current market capitalization of $478 million.
Maxwell Technologies, Inc. develops, manufactures and markets energy storage and power delivery products for transportation, industrial, telecommunications and other applications and microelectronic products for space and satellite applications. The Company focuses on three lines of products: Ultracapacitors, High-Voltage Capacitors and Radiation-Mitigated Microelectronic Products.
Northgate Minerals (AMEX:NXG) has lost 0.35% or one cent a share to settle at $2.86 a share with a light volume of 562,218 shares, compared to its average three-month volume of 3.9 million shares. For the past 52 weeks the stock has been trading between $2.41 and $3.54 with a current market capitalization of$832 million.
Northgate Minerals Corporation (Northgate) is a Canada-based gold and copper producing company with operations, development projects and exploration properties in Canada and Australia. The Company's assets are the Kemess mine, a low-grade open pit mine, which processes its ore through a flotation mill circuit in British Columbia, Canada (Kemess); Fosterville, an underground mine in Australia, which recovers gold through a bacterial oxidation, heated leach, flotation and carbon-in-leach circuit (Fosterville).
PDL BioPharma (NASDAQ:PDLI) has gained 14.61% or $.71 to settle at $5.57 a share with a surging volume of 11,740,000 shares which is at least five times larger than its average three-month volume of 2.6 million shares. For the past 52 weeks the stock has been trading between $4.66 and $7.30 with a current market capitalization of 780 million shares and a trailing 12 month P/E ratio of 7.00.
PDL BioPharma, Inc. (PDL) is engaged in the management of its antibody humanization patents and royalty assets, which consist of the Company's Queen et al. patents and license agreements with several biotechnology and pharmaceutical companies.
Derma Sciences (NASDAQ:DSCI) has gained 5.44% or $.56 to settle at $10.85 a share with an increased volume of 97,576 shares compared to its average three-month volume of 79,700 shares. For the past 52 weeks the stock has been trading between $4.40 and $12.72 a share with a current market capitalization of $72 million.
Derma Sciences, Inc. (Derma Sciences) is a specialty medical device/pharmaceutical company with a primary focus on wound care. The Company is engaged in the manufacture, marketing and sale of three dermatological related product lines: wound care, wound closure and specialty securement devices, and skin care. Its customers consist of various health care agencies and institutions, such as wound care centers, long-term care facilities, hospitals, home healthcare agencies, physicians' offices and closed door pharmacies.
Brigus Gold (AMEX:BRD) has gained 4.52% or seven cents a share to settle at $1.62 with a surging volume of 984,000 shares, compared to its average three-month volume of 1 million shares. For the past 52 weeks the stock has been trading between $1.05 and $5.20 a share with a current market capitalization of $290 million.
Brigus Gold Corp., formerly Apollo Gold Corporation (Apollo), is engaged in gold mining, including extraction, and processing, as well as related activities, including exploration and development. The Company owns Black Fox, an open pit and underground mine and mill located near Matheson in the Province of Ontario, Canada (Black Fox). It also owns Mexican subsidiaries, which own concessions at the Huizopa exploration project, located in the Sierra Madres in Chihuahua, Mexico.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report
